Literature DB >> 12611201

[Dextropropoxyphene hepatotoxicity: four cases and literature review].

L Bergeron1, C Guy, M Ratrema, M N Beyens, G Mounier, M Ollagnier.   

Abstract

We report 4 cases of hepatic injury in patients treated with a dextropropoxyphene-paracetamol combination in which the causal relationship with dextropropoxyphene can be suspected. These four cases show similarities with the 29 cases found in international publications. Hepatotoxicity occurs more frequently among old patients and women. Clinically, this condition can mimic a biliary tract disease with sometimes few or no symptoms. Biochemical criteria can show cholestatic, mixed or cytolytic hepatitis. Intrahepatic cholestasis may be found in liver biopsies sometimes suggesting cholangitis. Outcome is favourable on withdrawal of the drug. The mechanism of action of dextropropoxyphene is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12611201

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  3 in total

Review 1.  Dextropropoxyphene: safety and efficacy in older patients.

Authors:  David J Goldstein; Dennis C Turk
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).

Authors:  Neda Tavassoli; Maryse Lapeyre-Mestre; Agnès Sommet; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

Review 3.  Opioid Drugs in Patients With Liver Disease: A Systematic Review.

Authors:  Hassan Soleimanpour; Saeid Safari; Kavous Shahsavari Nia; Sarvin Sanaie; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.